NYSEARCA:XBISPDR S&P Biotech ETF Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding SPDR S&P Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $104.11 +0.55 (+0.53 %) (As of 06/1/2020 04:00 PM ET) Add Share Today's Range$102.81Now: $104.11▼$104.7550-Day Range$83.30MA: $97.14▼$106.0552-Week Range$62.94Now: $104.11▼$108.05Volume5.98 million shsAverage Volume7.23 million shsMarket Capitalization$4.93 billionP/E RatioN/ADividend Yield0.01%BetaN/A ProfileAdvanced ChartDividendInstitutional OwnershipHeadlinesOptions ChainSocial Media SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for SPDR S&P Biotech ETF. Previous Next 2.3 Community Rank Outperform VotesSPDR S&P Biotech ETF has received 114 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSPDR S&P Biotech ETF has received 133 “underperform” votes. (Add your “underperform” vote.)Community SentimentSPDR S&P Biotech ETF has received 53.85% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about SPDR S&P Biotech ETF and other stocks. Vote “Outperform” if you believe XBI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe XBI will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldSPDR S&P Biotech ETF has a dividend yield of 0.01%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthSPDR S&P Biotech ETF does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, SPDR S&P Biotech ETF insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.46 out of 5 stars Basic Details Issuer SSgA Fund NameSPDR S&P Biotech ETF Tax ClassificationRegulated Investment Company SymbolNYSEARCA:XBI Inception Date1/31/2006 Fund ManagerMichael Feehily, Karl Schneider, Raymond Donofrio Webwww.spdrs.com Phone+1-866-7872257 Fund Focus Asset ClassEquity BenchmarkS&P Biotech Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Fund Statistics Assets Under Management$4.69 billion Average Daily Volume$7.33 million Discount/Premium-0.11% ETF Expenses Management Fee0.35% Other Expenses0.00% Total Expenses0.35% Fee Waiver0.00% Net Expenses0.35%Administrator, Advisor and Custodian AdministratorSSGA Funds Management, Inc. AdvisorSSgA Funds Management, Inc. CustodianState Street Bank and Trust Company DistributorState Street Global Advisors Funds Distributors, LLC Transfer AgentState Street Bank and Trust Company Trustee Lead Market MakerVirtu Financial AMEX:XBI Rates by TradingView Receive XBI News and Ratings via Email Sign-up to receive the latest news and ratings for XBI and its competitors with MarketBeat's FREE daily newsletter. SPDR S&P Biotech ETF (NYSEARCA:XBI) Frequently Asked Questions How has SPDR S&P Biotech ETF's stock been impacted by COVID-19 (Coronavirus)? SPDR S&P Biotech ETF's stock was trading at $79.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, XBI shares have increased by 31.8% and is now trading at $104.11. View which stocks have been most impacted by Coronavirus. How often does SPDR S&P Biotech ETF pay dividends? What is the dividend yield for SPDR S&P Biotech ETF? SPDR S&P Biotech ETF announced a quarterly dividend on Friday, December 20th. Investors of record on Monday, December 23rd will be paid a dividend of $0.0009 per share on Thursday, December 26th. This represents a $0.00 dividend on an annualized basis and a dividend yield of 0.00%. The ex-dividend date is Friday, December 20th. View SPDR S&P Biotech ETF's dividend history. Has SPDR S&P Biotech ETF been receiving favorable news coverage? Media stories about XBI stock have trended somewhat negative recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. SPDR S&P Biotech ETF earned a news sentiment score of -1.0 on InfoTrie's scale. They also gave news headlines about the exchange traded fund a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutSPDR S&P Biotech ETF. What other stocks do shareholders of SPDR S&P Biotech ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Biotech ETF investors own include iShares Nasdaq Biotechnology ETF (IBB), NVIDIA (NVDA), Netflix (NFLX), Walt Disney (DIS), Intel (INTC), Alibaba Group (BABA), Gilead Sciences (GILD), Micron Technology (MU), Cisco Systems (CSCO) and Pfizer (PFE). Who are SPDR S&P Biotech ETF's key executives? SPDR S&P Biotech ETF's management team includes the following people: James E. Ross, President, Trustee (Age 52)Peter A. Ambrosini, Chief Compliance Officer (Age 69)Michael P. Riley, Vice President (Age 44)Gary L. French, Treasurer (Age 64)John W. Clark, Assistant Treasurer (Age 46)Matthew W. Flaherty, Assistant Treasurer (Age 42)Chad C. Hallett, Assistant Treasurer of Street tracks series trust (Age 47)Mary Moran Zeven, Secretary (Age 52)Scott M. Zoltowski, Assistant Secretary (Age 44)Dave Kelly, Independent Trustee What is SPDR S&P Biotech ETF's stock symbol? SPDR S&P Biotech ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XBI." Who are SPDR S&P Biotech ETF's major shareholders? SPDR S&P Biotech ETF's stock is owned by many different retail and institutional investors. Top institutional investors include JPMorgan Chase & Co. (20.93%), Morgan Stanley (17.79%), Healthcare of Ontario Pension Plan Trust Fund (4.89%), Wells Fargo & Company MN (1.90%), SG Americas Securities LLC (1.24%) and Two Sigma Advisers LP (0.90%). Which institutional investors are selling SPDR S&P Biotech ETF stock? XBI stock was sold by a variety of institutional investors in the last quarter, including Healthcare of Ontario Pension Plan Trust Fund, Wells Fargo & Company MN, Two Sigma Advisers LP, HBK Investments L P, Orbimed Advisors LLC, Thrivent Financial for Lutherans, Chatham Capital Group Inc., and Carnegie Capital Asset Management LLC. Which institutional investors are buying SPDR S&P Biotech ETF stock? XBI stock was bought by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Morgan Stanley, SG Americas Securities LLC, tru Independence LLC, Meitav Dash Investments Ltd., Advisor Group Holdings Inc., Private Advisor Group LLC, and CMH Wealth Management LLC. How do I buy shares of SPDR S&P Biotech ETF? Shares of XBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is SPDR S&P Biotech ETF's stock price today? One share of XBI stock can currently be purchased for approximately $104.11. How big of a company is SPDR S&P Biotech ETF? SPDR S&P Biotech ETF has a market capitalization of $4.93 billion. What is SPDR S&P Biotech ETF's official website? The official website for SPDR S&P Biotech ETF is www.spdrs.com. How can I contact SPDR S&P Biotech ETF? SPDR S&P Biotech ETF's mailing address is One Lincoln Street, Boston, 02111, United States. The exchange traded fund can be reached via phone at +1-866-7872257. This page was last updated on 6/1/2020 by MarketBeat.com Staff
